Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis

Gruntzig, 1979, Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty, N Engl J Med, 301, 61, 10.1056/NEJM197907123010201 Simsek, 2010, JACC Cardiovasc Interv, 3, 1051, 10.1016/j.jcin.2010.08.003 Stolker, 2010, Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry, Circ Cardiovasc Interv, 3, 327, 10.1161/CIRCINTERVENTIONS.110.946939 Jukema, 2012, Restenosis after PCI. Part 2: prevention and therapy, Nat Rev Cardiol, 9, 79, 10.1038/nrcardio.2011.148 Windecker, 2014, Eur Heart J, 35, 2541, 10.1093/eurheartj/ehu278 Mehran, 1999, Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome, Circulation, 100, 1872, 10.1161/01.CIR.100.18.1872 Popma, 1994, Qualitative and quantitative angiography, 1052 Steinberg, 2009, Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents, Am J Cardiol, 103, 491, 10.1016/j.amjcard.2008.09.107 Alfonso, 2009, Treatment of patients with in-stent restenosis, EuroIntervention, 5, D70 Gonzalo, 2009, Optical coherence tomography patterns of stent restenosis, Am Heart J, 158, 284, 10.1016/j.ahj.2009.06.004 Alfonso, 2003, A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis, J Am Coll Cardiol, 4, 796, 10.1016/S0735-1097(03)00852-0 Alfonso, 2006, A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial, J Am Coll Cardiol, 47, 2152, 10.1016/j.jacc.2005.10.078 Kastrati, 2005, Sirolimus-eluting stent or paclitaxel-eluting stent versus balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial, JAMA, 293, 165, 10.1001/jama.293.2.165 Alfonso, 2010, Treatment of drug-eluting stent restenosis the new pilgrimage: quo vadis?, J Am Coll Cardiol, 55, 2717, 10.1016/j.jacc.2010.03.026 Cosgrave, 2006, Drug-eluting stent restenosis the pattern predicts the outcome, J Am Coll Cardiol, 47, 2399, 10.1016/j.jacc.2006.02.046 Kitahara, 2009, Rerestenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals, Circ J, 73, 867, 10.1253/circj.CJ-08-0851 Alfonso, 2015, Mechanisms of balloon angioplasty and repeat stenting in patients with drug-eluting in-stent restenosis, Int J Cardiol, 178, 213, 10.1016/j.ijcard.2014.10.139 Arikawa, 2015, Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis, Cardiovasc Revasc Med, 16, 27, 10.1016/j.carrev.2014.11.002 Cosgrave, 2007, Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent, Am Heart J, 153, 354, 10.1016/j.ahj.2006.12.009 Colombo, 2003, Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation, Circulation, 107, 2178, 10.1161/01.CIR.0000070592.04766.36 Fujii, 2004, Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis, Circulation, 109, 1085, 10.1161/01.CIR.0000121327.67756.19 Okumura, 2007, Restenosis and stent fracture following sirolimus-eluting stent (SES) implantation, Circ J, 71, 1669, 10.1253/circj.71.1669